Europe - Coronavirus Test Kits Market by End-user and Type - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 147 SKU: IRTNTR43247

Europe - Coronavirus Test Kits Market 2023-2027 

The Europe-Conavirus Test Kits Market size is estimated to decline at a CAGR of -23.8% between 2022 and 2027. The market size is forecast to increase by USD -17.29 billion. The growth of the market depends on several factors play a crucial role in the market's growth, such as 

This Europe coronavirus test kits market report extensively covers market segmentation by end-user (government and non-government), and type (rapid test kit, RT-PCR, and others). The report also covers an in-depth analysis of drivers, trends, and challenges. 

Europe Coronavirus Test Kits Market Overview

To know more about Europe Coronavirus Test Kits Market size Download Report Sample

Key Europe Coronavirus Test Kits Market Driver

The rising focus on preventing the spread of the COVID-19 pandemic is notably driving market growth. Healthcare organizations and governments across the world have created guidelines and protocols for the effective control of the outbreak of pandemics such as COVID-19. These organizations include international and national authorities, such as the WHO and the ECDC. Such organizations mainly focus on supporting the establishment of a standard protocol, framework, and national and international plans for mitigating and preventing the COVID-19 pandemic by ensuring proper diagnostics and treatment to patients globally. 

Moreover, the rising focus on the prevention of the spread of the COVID-19 pandemic has led to advances in innovative diagnostic products for coronavirus globally, including Europe which subsequently resulted in Europe - coronavirus test kits market expansion. These factors will boost the growth of the coronavirus test kits market in Europe.

Key Europe Coronavirus Test Kits Market Trends

Increasing demand for point-of-care diagnostics is an emerging trend shaping the market growth. The novel coronavirus disease (COVID-19) outbreak has posed a major challenge to national and international health authorities across the world, including WHO, the ECDC, and the National Institutes of Health (NIH). These authorities have been making significant efforts to strengthen surveillance to prevent the spread of the disease and increase the diagnostic capacities of laboratories in Europe. Moreover, the lack of testing infrastructure in most European countries has been a major challenge to such initiatives. Diagnostic kit manufacturers are offering antigen detection-based RIDT kits to overcome infrastructure-related issues and are providing efficient coronavirus diagnostic capabilities to healthcare practitioners, irrespective of their geographical location.

For instance, Cepheid Xpert Xpress SARS-CoV-2 is the first coronavirus diagnostic test that can be conducted entirely at the point of care. This US FDA-approved POC testing kit delivers results in about 45 minutes, which is much faster than traditional tests that require a sample to be sent to a centralized lab. Thus, the availability of advanced point-of-care products in the market is increasing the adoption of coronavirus test kits by end-users and promoting revenue growth of the coronavirus test kits market in Europe. 

Major Europe Coronavirus Test Kits Market Challenge

Inadequate testing facilities are a significant challenge hindering the market growth. Germany, France, and the UK were some of the worst-affected countries. Countries such as the UK, Italy, France, and Spain witnessed the highest number of COVID-19-related deaths globally due to the high geriatric population and lower testing capacity. The UK and Italy reported almost six times more deaths than China, where the virus first emerged in late 2019. European countries, such as Italy and Spain, were unable to slow down the spread of the contagion due to the focus on people with severe symptoms in areas with a high epidemic intensity. 

However, most European countries, including Spain and Italy, have already reported the saturation of their healthcare systems due to the high patient loads requiring intensive care which can restrict the Europe - coronavirus test kits market growth. Thus, inadequate testing facilities can impede the growth of the coronavirus test kits market in Europe during the forecast period.

Europe Coronavirus Test Kits Market Largest Segment and Geographic Analysis

End-user Segment Analysis 

The government segment is estimated to witness significant growth during the forecast period. This segment includes government regulatory authorities such as WHO and the ECDC and government-run laboratories in various countries. WHO recommends that countries with inadequate testing capacity and national laboratories with limited experience in COVID-19 testing may send their first five positive and the first ten negative COVID-19 samples to one of the five WHO referral laboratories in Europe for confirmatory testing.

Get a glance at the market segment contribution  View the PDF Sample

In the UK, in addition to WHO reference laboratories, designated Public Health England (PHE) regional laboratories offer testing facilities for coronavirus. The Europe - coronavirus test kits market, especially in the UK is expected to grow in 2020, owing to the government's efforts to expand the infrastructure for mass testing. On March 25, 2020, the government stated that it was testing personal blood-testing kits. The Government of the UK has ordered 3.5 million antibody test kits and is currently testing the feasibility of these test kits. Therefore, the demand for coronavirus test kits in Europe from the government segment is expected to reduce owing to the success of the vaccination program, which in turn will negatively impact the growth of the coronavirus test kits market in Europe during the forecast period.

Who are the Major Europe Coronavirus Test Kits Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

3D Biomedicine Science and Technology Co. Ltd. - The company offers coronavirus test kits such as Fluorescent qPCR-based COVID-19 plus Influenza AB Combo Test Kit.

The research report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • Abbott Laboratories
  • altona Diagnostics GmbH
  • BGI Genomics Co. Ltd.
  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • BIOSYNEX SA
  • Bruker Corp.
  • Co Diagnostics Inc.
  • Danaher Corp.
  • Edinburgh Genetics Ltd.
  • F. Hoffmann La Roche Ltd.
  • MultiplexDX
  • PerkinElmer Inc.
  • QIAGEN NV
  • Robert Bosch GmbH
  • Sd Biosensor Inc.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • ZEKMED

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Segment Overview

The Europe Coronavirus Test Kits Market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • End-user Outlook
    • Government
    • Non-government
  • Type Outlook
    • Rapid test kit
    • RT-PCR
    • Others

Europe Coronavirus Test Kits Market Scope

Report Coverage

Details

Page number

147

Base year

2022

Forecast period

2023-2027

Growth momentum & CAGR

Decelerate at a CAGR of -23.8%

Market growth 2023-2027

USD -17.29 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

-14.83

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc., Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, PerkinElmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Europe Coronavirus Test Kits Market In Regional Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the market  size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across Europe
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 18: Five forces analysis - Comparison between 2022 and 2027
    • 4.2 Bargaining power of buyers
      • Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 4.3 Bargaining power of suppliers
      • Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 4.4 Threat of new entrants
      • Exhibit 21: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 4.5 Threat of substitutes
      • Exhibit 22: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 4.6 Threat of rivalry
      • Exhibit 23: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 4.7 Market condition
      • Exhibit 24: Chart on Market condition - Five forces 2022 and 2027

    5 Market Segmentation by End-user

    • 5.1 Market segments
      • Exhibit 25: Chart on End-user - Market share 2022-2027 (%)
      • Exhibit 26: Data Table on End-user - Market share 2022-2027 (%)
    • 5.2 Comparison by End-user
      • Exhibit 27: Chart on Comparison by End-user
      • Exhibit 28: Data Table on Comparison by End-user
    • 5.3 Government - Market size and forecast 2022-2027
      • Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%)
      • Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%)
    • 5.4 Non-government - Market size and forecast 2022-2027
      • Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%)
      • Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%)
    • 5.5 Market opportunity by End-user
      • Exhibit 37: Market opportunity by End-user ($ billion)
      • Exhibit 38: Data Table on Market opportunity by End-user ($ billion)

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 39: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 40: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 41: Chart on Comparison by Type
      • Exhibit 42: Data Table on Comparison by Type
    • 6.3 Rapid test kit - Market size and forecast 2022-2027
      • Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%)
      • Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%)
    • 6.4 RT-PCR - Market size and forecast 2022-2027
      • Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%)
    • 6.5 Others - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.6 Market opportunity by Type
      • Exhibit 55: Market opportunity by Type ($ billion)
      • Exhibit 56: Data Table on Market opportunity by Type ($ billion)

    7 Customer Landscape

    • 7.1 Customer landscape overview
      • Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    8 Geographic Landscape

    • 8.1 Geographic segmentation
      • Exhibit 58: Chart on Market share by geography - 2022-2027 (%)
      • Exhibit 59: Data Table on Market share by geography - 2022-2027 (%)
    • 8.2 Geographic comparison
      • Exhibit 60: Chart on Geographic comparison
      • Exhibit 61: Data Table on Geographic comparison
    • 8.3 UK - Market size and forecast 2022-2027
      • Exhibit 62: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 63: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 64: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 65: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 8.4 Spain - Market size and forecast 2022-2027
      • Exhibit 66: Chart on Spain - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 68: Chart on Spain - Year-over-year growth 2022-2027 (%)
      • Exhibit 69: Data Table on Spain - Year-over-year growth 2022-2027 (%)
    • 8.5 Russia - Market size and forecast 2022-2027
      • Exhibit 70: Chart on Russia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 72: Chart on Russia - Year-over-year growth 2022-2027 (%)
      • Exhibit 73: Data Table on Russia - Year-over-year growth 2022-2027 (%)
    • 8.6 France - Market size and forecast 2022-2027
      • Exhibit 74: Chart on France - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 75: Data Table on France - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 77: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 8.7 Rest of Europe - Market size and forecast 2022-2027
      • Exhibit 78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%)
    • 8.8 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ billion)
      • Exhibit 83: Data Table on Market opportunity by geography ($ billion)

    9 Drivers, Challenges, and Trends

    • 9.1 Market drivers
      • 9.2 Market challenges
        • 9.3 Impact of drivers and challenges
          • Exhibit 84: Impact of drivers and challenges in 2022 and 2027
        • 9.4 Market trends

          10 Vendor Landscape

          • 10.1 Overview
            • 10.2 Vendor landscape
              • Exhibit 85: Overview on Criticality of inputs and Factors of differentiation
            • 10.3 Landscape disruption
              • Exhibit 86: Overview on factors of disruption
            • 10.4 Industry risks
              • Exhibit 87: Impact of key risks on business

            11 Vendor Analysis

            • 11.1 Vendors covered
              • Exhibit 88: Vendors covered
            • 11.2 Market positioning of vendors
              • Exhibit 89: Matrix on vendor position and classification
            • 11.3 3D Biomedicine Science and Technology Co. Ltd.
              • Exhibit 90: 3D Biomedicine Science and Technology Co. Ltd. - Overview
              • Exhibit 91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service
              • Exhibit 92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings
            • 11.4 Abbott Laboratories
              • Exhibit 93: Abbott Laboratories - Overview
              • Exhibit 94: Abbott Laboratories - Business segments
              • Exhibit 95: Abbott Laboratories - Key news
              • Exhibit 96: Abbott Laboratories - Key offerings
              • Exhibit 97: Abbott Laboratories - Segment focus
            • 11.5 altona Diagnostics GmbH
              • Exhibit 98: altona Diagnostics GmbH - Overview
              • Exhibit 99: altona Diagnostics GmbH - Product / Service
              • Exhibit 100: altona Diagnostics GmbH - Key offerings
            • 11.6 BGI Genomics Co. Ltd.
              • Exhibit 101: BGI Genomics Co. Ltd. - Overview
              • Exhibit 102: BGI Genomics Co. Ltd. - Product / Service
              • Exhibit 103: BGI Genomics Co. Ltd. - Key offerings
            • 11.7 Bio Rad Laboratories Inc.
              • Exhibit 104: Bio Rad Laboratories Inc. - Overview
              • Exhibit 105: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 106: Bio Rad Laboratories Inc. - Key news
              • Exhibit 107: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 108: Bio Rad Laboratories Inc. - Segment focus
            • 11.8 bioMerieux SA
              • Exhibit 109: bioMerieux SA - Overview
              • Exhibit 110: bioMerieux SA - Product / Service
              • Exhibit 111: bioMerieux SA - Key offerings
            • 11.9 BIOSYNEX SA
              • Exhibit 112: BIOSYNEX SA - Overview
              • Exhibit 113: BIOSYNEX SA - Product / Service
              • Exhibit 114: BIOSYNEX SA - Key offerings
            • 11.10 Bruker Corp.
              • Exhibit 115: Bruker Corp. - Overview
              • Exhibit 116: Bruker Corp. - Business segments
              • Exhibit 117: Bruker Corp. - Key news
              • Exhibit 118: Bruker Corp. - Key offerings
              • Exhibit 119: Bruker Corp. - Segment focus
            • 11.11 Co Diagnostics Inc.
              • Exhibit 120: Co Diagnostics Inc. - Overview
              • Exhibit 121: Co Diagnostics Inc. - Product / Service
              • Exhibit 122: Co Diagnostics Inc. - Key news
              • Exhibit 123: Co Diagnostics Inc. - Key offerings
            • 11.12 Danaher Corp.
              • Exhibit 124: Danaher Corp. - Overview
              • Exhibit 125: Danaher Corp. - Business segments
              • Exhibit 126: Danaher Corp. - Key news
              • Exhibit 127: Danaher Corp. - Key offerings
              • Exhibit 128: Danaher Corp. - Segment focus
            • 11.13 Edinburgh Genetics Ltd.
              • Exhibit 129: Edinburgh Genetics Ltd. - Overview
              • Exhibit 130: Edinburgh Genetics Ltd. - Product / Service
              • Exhibit 131: Edinburgh Genetics Ltd. - Key offerings
            • 11.14 F. Hoffmann La Roche Ltd.
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
            • 11.15 QIAGEN NV
              • Exhibit 137: QIAGEN NV - Overview
              • Exhibit 138: QIAGEN NV - Product / Service
              • Exhibit 139: QIAGEN NV - Key news
              • Exhibit 140: QIAGEN NV - Key offerings
            • 11.16 Thermo Fisher Scientific Inc.
              • Exhibit 141: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 142: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 143: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus
            • 11.17 ZEKMED
              • Exhibit 146: ZEKMED - Overview
              • Exhibit 147: ZEKMED - Product / Service
              • Exhibit 148: ZEKMED - Key offerings

            12 Appendix

            • 12.1 Scope of the report
              • 12.2 Inclusions and exclusions checklist
                • Exhibit 149: Inclusions checklist
                • Exhibit 150: Exclusions checklist
              • 12.3 Currency conversion rates for US$
                • Exhibit 151: Currency conversion rates for US$
              • 12.4 Research methodology
                • Exhibit 152: Research methodology
                • Exhibit 153: Validation techniques employed for market sizing
                • Exhibit 154: Information sources
              • 12.5 List of abbreviations
                • Exhibit 155: List of abbreviations
              • generated by emerging segments in healthcare: Growing adoption of healthcare supplies for home-based healthcare, home medical devices, and other advanced application areas such as robotic surgery will aid in the growth of this market.

                Research Framework

                Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                INFORMATION SOURCES

                Primary sources

                • Manufacturers and suppliers
                • Channel partners
                • Industry experts
                • Strategic decision makers

                Secondary sources

                • Industry journals and periodicals
                • Government data
                • Financial reports of key industry players
                • Historical data
                • Press releases

                DATA ANALYSIS

                Data Synthesis

                • Collation of data
                • Estimation of key figures
                • Analysis of derived insights

                Data Validation

                • Triangulation with data models
                • Reference against proprietary databases
                • Corroboration with industry experts

                REPORT WRITING

                Qualitative

                • Market drivers
                • Market challenges
                • Market trends
                • Five forces analysis

                Quantitative

                • Market size and forecast
                • Market segmentation
                • Geographical insights
                • Competitive landscape

                PURCHASE FULL REPORT OF

                test kits market for corona virus testing market

                Key Questions Answered

                • What are the key global market and the regional market share?
                • What are the revenue-generating key market segments?
                • What are the key factors driving and challenging this market’s growth?
                • Who are the key market vendors and their growth strategies?
                • What are the latest trends influencing the growth of this market?
                • What are the variables influencing the market growth in the primary regions?
                • What are the factors influencing the growth of the parent market?

                Why should you prefer Technavio's market insights report?

                • Off-the-shelf research reports
                • Reports can be tailored to meet the customer's needs
                • Trusted by more than 100 fortune 500 organizations
                • Information about the market's key drivers, trends, and challenges
                • Parent market analysis
                • Every week, 50,000 people visit our subscription platform
                • Detailed vendors report with competitive landscape
                • Covid-19 impact and recovery analysis
                • Data on revenue-generating market segments
                • Details on the market shares of various regions
                • Five-force market analysis